These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6112386)

  • 21. Aspirin dose in prevention of transient ischaemic attacks.
    Olsson JE
    Lancet; 1979 Apr; 1(8120):830. PubMed ID: 86079
    [No Abstract]   [Full Text] [Related]  

  • 22. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
    Offerhaus L
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2673; author reply 2673-4. PubMed ID: 17205947
    [No Abstract]   [Full Text] [Related]  

  • 23. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.
    Halkes PH; Gray LJ; Bath PM; Diener HC; Guiraud-Chaumeil B; Yatsu FM; Algra A
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1218-23. PubMed ID: 18535024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group.
    Lancet; 1987 Dec; 2(8572):1351-4. PubMed ID: 2890951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP; Lodder J
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
    Gibbs CR; Li-Saw-Hee FL; Lip GY
    Scott Med J; 1998 Feb; 43(1):6. PubMed ID: 9533251
    [No Abstract]   [Full Text] [Related]  

  • 28. The European Stroke Prevention Study (ESPS): results by arterial distribution.
    Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
    Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.
    Verro P; Gorelick PB; Nguyen D
    Stroke; 2008 Apr; 39(4):1358-63. PubMed ID: 18323511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials.
    Li X; Zhou G; Zhou X; Zhou S
    J Neurol Sci; 2013 Sep; 332(1-2):92-6. PubMed ID: 23871093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
    Diener HC
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366496
    [No Abstract]   [Full Text] [Related]  

  • 34. European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly.
    Sivenius J; Riekkinen PJ; Laakso M; Smets P; Lowenthal A
    Acta Neurol Scand; 1993 Feb; 87(2):111-4. PubMed ID: 8442393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
    Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
    Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group.
    Stroke; 1985; 16(3):406-15. PubMed ID: 2860740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results.
    Tijssen JG
    Neurology; 1998 Sep; 51(3 Suppl 3):S15-6. PubMed ID: 9744825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks.
    Matías-Guiu J; Dávalos A; Picó M; Monasterio J; Vilaseca J; Codina A
    Acta Neurol Scand; 1987 Dec; 76(6):413-21. PubMed ID: 3324618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of a slower than standard dose escalation scheme for dipyridamole on headaches in secondary prevention therapy of strokes: a randomized, open-label trial (DOSE).
    de Vos-Koppelaar NC; Kerkhoff H; de Vogel EM; Zock E; Dieleman HG
    Cerebrovasc Dis; 2014; 37(4):285-9. PubMed ID: 24819911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persantine Aspirin Trial in cerebral ischemia. The American-Canadian Co-operative Study Group.
    Stroke; 1983; 14(1):99-103. PubMed ID: 6337428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.